Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

Arturo Vega-Ruiz, Jorge E. Cortes, Matjaz Sever, Taghi Manshouri, Alfonso Quintás-Cardama, Raja Luthra, Hagop M. Kantarjian, Srdan Verstovsek

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis'. Together they form a unique fingerprint.

Medicine & Life Sciences